Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leathanach 1 ó 60 torthaí
Plasma-like substance
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The invention relates to the field of plasma-like solutions which may be used to treat hypovolemic subjects or to substitute for the blood or plasma of a subject.
BACKGROUND
Perfusion solutions and blood substitutes are known. The blood substitutes of Collins et al, Kidney
Plasma-like substance
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The invention relates to the field of plasma-like solutions which may be used to treat hypovolemic subjects or to substitute for the blood or plasma of a subject.
BACKGROUND
Perfusion solutions and blood substitutes are known. The blood substitutes of Collins et al, Kidney
Plasma-like substance
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The invention relates to the field of plasma-like solutions which may be used to treat hypovolemic subjects or to substitute for the blood or plasma of a subject.
BACKGROUND
Perfusion solutions and blood substitutes are known. The blood substitutes of Collins et al, Kidney
Plasma-like substance
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The invention relates to the field of plasma-like solutions which may be used to treat hypovolemic subjects or to substitute for the blood or plasma of a subject.
BACKGROUND
Perfusion solutions and blood substitutes are known. The blood substitutes of Collins et al, Kidney
Plasma-like substance
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The invention relates to the field of plasma-like solutions which may be used to treat hypovolemic subjects or to substitute for the blood or plasma of a subject.
BACKGROUND
Perfusion solutions and blood substitutes are known. The blood substitutes of Collins et al, Kidney
Plasma-like substance
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The invention relates to the field of plasma-like solutions which may be used to treat hypovolemic subjects or to substitute for the blood or plasma of a subject.
BACKGROUND
Perfusion solutions and blood substitutes are known. The blood substitutes of Collins et al, Kidney
Afamin: a human serum albumin-like gene
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
Generally, the invention relates to the field of human serum proteins that are functionally and structurally similar to the related proteins: human serum albumin (ALB), human a-fetoprotein (AFP), and vitamin D-binding protein (VDB).
BACKGROUND OF THE INVENTION
The human serum
Afamin: a human serum albumin-like protein
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
Generally, the invention relates to the field of human serum proteins that are functionally and structurally similar to the related proteins: human serum albumin (ALB), human a-fetoprotein (AFP), and vitamin D-binding protein (VDB).
BACKGROUND OF THE INVENTION
The human serum
Glucagon-like peptide-1 derivatives and their pharmaceutical use
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 4, 2010, is named 7668204US_SeqList.txt and is 5,582 bytes in size.
FIELD OF THE
Glucagon-Like Peptide-1 derivatives and their pharmaceutical use
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn.371 national stage application of International Patent Application PCT/EP2008/061755 (published as WO 2009/030738), filed Sep. 5, 2008, which claimed priority of European Patent Applications 07115746.5, filed Sep. 5, 2007
Serum albumin binding molecules
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Nov. 29, 2016, is named MXI_523DVCN_Sequence_Listing.txt and is 548,299 bytes in size.
INTRODUCTION
The
Serum albumin binding molecules
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
INTRODUCTION
The utility of many therapeutics, particularly biologicals such as peptides, polypeptides and polynucleotides, suffer from inadequate serum half-lives. This necessitates the administration of such therapeutics at high frequencies and/or higher doses, or the use of sustained release
Serum albumin binding molecules
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Aug. 11, 2011, is named COTH5291.txt and is 548,400 bytes in size.
INTRODUCTION
The utility
Fusion protein comprising albumin and retinol-binding protein
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
SEQUENCE LISTING
The instant application contains a Sequence Listing which is identical to the sequence listing of the parent application Ser. No. 14/002,034 filed Aug. 28, 2013.
TECHNICAL FIELD
The present invention relates to a fusion protein comprising albumin and retinol-binding protein, which
Fusion protein comprising albumin and retinol-binding protein
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
SEQUENCE LISTING
The instant application contains a Sequence Listing which identical to the sequence listing of the parent application Ser. No. 15/001,720, filed Jan. 20, 2016.
TECHNICAL FIELD
The present invention relates to a fusion protein comprising albumin and retinol-binding protein, which is
An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht
- Oibreacha i 55 teanga
- Leigheasanna luibhe le tacaíocht ón eolaíocht
- Aitheantas luibheanna de réir íomhá
- Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
- Léigh foilseacháin eolaíochta a bhaineann le do chuardach
- Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
- Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní
Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe
